Dr. David J. Dipiazza, MD

Dr. Dipiazza practices at Advanced Urology Institute in New Port Richey, Florida.

Dr. Dipiazza's NPI, 1356347280, was assigned on June 24, 2005. Dr. Dipiazza graduated from Rutgers New Jersey Medical School in 1998. Dr. Dipiazza holds Florida license ME90068.

Dr. Dipiazza's primary practice is Advanced Urology Institute, at 2148 Duck Slough Blvd, New Port Richey, FL 34655 in Pasco County. The practice phone is (352) 391-6494.

Dr. Dipiazza's primary practice is Advanced Urology Institute in New Port Richey, Florida. Dr. Dipiazza is also affiliated with BayCare Morton Plant North Bay Hospital. The medical group on file is Advanced Urology Institute. Dmand AI also links Dr. Dipiazza to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dipiazza practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Dipiazza's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Dipiazza is board certified in female pelvic medicine and reconstructive surgery by the American Board of Urology. Dmand AI has Dr. Dipiazza's licenses on file in 2 states: Florida and New Jersey.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and pelvic prolapse among the conditions Dr. Dipiazza treats.

CMS data shows 3,519 Medicare services from Dr. Dipiazza across 28 procedure codes in 2024, for 593 Medicare patients. Medicare paid $180,104 for them.

CMS counts 593 Medicare patients who saw Dr. Dipiazza in 2024. The largest group is 75 to 84, with 261 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dipiazza's median patient age at 70, with 36% women.

In 2024, Dr. Dipiazza wrote 2,171 Medicare Part D claims for 696 patients. 85% of them were for generic drugs. CMS names the drug for 2,029 of them, across 27 drugs with 11 or more claims each, at $573,176 in total drug cost. In 2023, CMS named 1,887 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Dipiazza for performance year 2024, reported as part of a group. Dr. Dipiazza accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Dipiazza. Dr. Dipiazza's most frequent co-author is Nancy Jean Lobby, DO.

CMS Open Payments shows 483 general payments to Dr. Dipiazza from 66 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Axonics, Inc. paid the most, $1,591.

Dmand AI lists 1 award for Dr. Dipiazza, most recently CMS Stage 1 EHR in 2013.

Dr. Dipiazza graduated from Rutgers New Jersey Medical School in 1998.

Dr. Dipiazza is in network with 15 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.